Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
about
Organic Nanomaterials and Their Applications in the Treatment of Oral DiseasesSmall solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapyCo-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.Aptamer-labeled PLGA nanoparticles for targeting cancer cells.Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatmentPaclitaxel Nano-Delivery Systems: A Comprehensive Review.Recent advancements in mechanical reduction methods: particulate systems.Sustained release of BMP-2 in a lipid-based microtube vehicle.Enzymatic polymerization of cyclic monomers in ionic liquids as a prospective synthesis method for polyesters used in drug delivery systems.Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells.Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies.Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method.Surface-enhanced Raman scattering detection and tracking of nanoprobes: enhanced uptake and nuclear targeting in single cells.ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO(2)) nanoparticles.Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles.Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables.Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures.Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.Development of Drug Loaded Nanoparticles Binding to Hydroxyapatite Based on a Bisphosphonate Modified Nonionic Surfactant
P2860
Q26766613-145DE069-0014-47BF-AF6E-A03A3563CC0FQ28390962-B63DE350-1913-4768-9599-457EDB6AD923Q31154684-5CEC651D-5E6D-441E-96AF-D777324316F5Q35071594-C8DE1A80-77DC-4210-B3BA-A413596C8198Q35673856-A2543A8B-7294-493F-A02C-D33F05C46D61Q36795898-A0833B38-CBF6-4776-8DED-D4680B83A950Q37250009-E63DDEB9-4C5C-4449-86FF-C2EE472829DBQ38132471-D0F1A42C-DFBD-454E-873C-4DE483E1CF37Q38269106-A485E2C2-156C-4298-A5FD-A3AB4C56D736Q38302750-AA44C5B4-8669-437A-99C0-202B396CF7C2Q38757246-CBAB07AD-D14C-435C-BF78-324C97A77DDAQ38968761-4C8EBB02-515B-4EB0-B03B-883C4AB825B7Q38975141-408335DB-6FC1-4222-B61F-8DBC3FC3EF80Q38981407-100CCFF2-887D-4C96-B830-7759A2180B4CQ39511265-397C1EB7-7614-4142-95A6-16973150A97DQ39603914-62750FCC-CF67-4067-8E6A-76BEF5C44E15Q39666159-E51A1F7A-B4B9-4F83-911B-0834F6ADBFE1Q39714462-DC32DCD3-FD4A-4CAF-96E5-FE1413A81904Q42626462-1B849F62-074B-4678-BD9E-6761A6CDDB91Q42740833-860558E4-1760-4CB2-AFB0-0B5277F60BA4Q44994152-D5CF3EA3-F65A-40D9-BA8A-2B38725DC67FQ46007249-5307F23E-5AFC-4CE0-BA4F-6889862C4D54Q46301020-FCAF646A-DE52-45A3-8453-1D5CBFDEB371Q55338133-F3EE5D0B-3F82-4D6E-9053-B7E4586C439AQ59113415-E827F8C2-F46E-4115-89E0-E5EDFEB455E6
P2860
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@ast
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@en
type
label
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@ast
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@en
prefLabel
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@ast
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@en
P1476
Poly(D,L-lactide-co-glycolide) ...... n for paclitaxel chemotherapy.
@en
P2093
Si-Shen Feng
Yuancai Dong
P304
P356
10.1016/J.IJPHARM.2007.04.031
P407
P577
2007-05-06T00:00:00Z